urea and tolcapone

urea has been researched along with tolcapone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Esperante, S; Pallarès, I; Pinheiro, F; Reverter, D; Santos, J; Varejão, N; Velázquez-Campoy, A; Ventura, S	1

Other Studies

2 other study(ies) available for urea and tolcapone

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis. The FEBS journal, 2021, Volume: 288, Issue:1 Topics: Amyloid; Amyloid Neuropathies, Familial; Antiparkinson Agents; Binding Sites; Cloning, Molecular; Crystallography, X-Ray; Drug Repositioning; Escherichia coli; Gene Expression; Genetic Vectors; Humans; Kinetics; Models, Molecular; Mutation; Neuroprotective Agents; Prealbumin; Protein Aggregates; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Denaturation; Protein Folding; Protein Interaction Domains and Motifs; Protein Multimerization; Protein Structure, Tertiary; Recombinant Proteins; Tolcapone; Urea	2021

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis.

The FEBS journal, 2021, Volume: 288, Issue:1

Topics: Amyloid; Amyloid Neuropathies, Familial; Antiparkinson Agents; Binding Sites; Cloning, Molecular; Crystallography, X-Ray; Drug Repositioning; Escherichia coli; Gene Expression; Genetic Vectors; Humans; Kinetics; Models, Molecular; Mutation; Neuroprotective Agents; Prealbumin; Protein Aggregates; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Denaturation; Protein Folding; Protein Interaction Domains and Motifs; Protein Multimerization; Protein Structure, Tertiary; Recombinant Proteins; Tolcapone; Urea

2021